Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panagiotis D Tsirigotis

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Medicine|March 18, 2011
The role of natural killer cells in hematopoietic stem cell transplantationPanagiotis D Tsirigotis, Igor B Resnick, Michael Y Shapira
Expert Opinion on Biological Therapy|April 14, 2006
Biological response modifiers as adjuncts to stem cell transplantationMichael Y Shapira, Igor B Resnick, Panagiotis D Tsirigotis, et al.
Leukemia & Lymphoma|March 9, 2013
Autologous transplant in multiple myeloma with an augmented conditioning protocolBadran Abu Zaid, Ali Abdul-Hai, Itamar Grotto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patientsIgor B Resnick, Panagiotis D Tsirigotis, Michael Y Shapira, et al.
Immunotherapy|July 20, 2010
Post-hematopoietic stem cell transplantion immune-mediated cytopeniasPanagiotis D Tsirigotis, Igor B Resnick, Reuven Or, et al.
British Journal of Haematology|May 18, 2006
Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimenIgor B Resnick, Memet Aker, Michael Y Shapira, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Medicine|March 18, 2011
The role of natural killer cells in hematopoietic stem cell transplantationPanagiotis D Tsirigotis, Igor B Resnick, Michael Y Shapira
Expert Opinion on Biological Therapy|April 14, 2006
Biological response modifiers as adjuncts to stem cell transplantationMichael Y Shapira, Igor B Resnick, Panagiotis D Tsirigotis, et al.
Leukemia & Lymphoma|March 9, 2013
Autologous transplant in multiple myeloma with an augmented conditioning protocolBadran Abu Zaid, Ali Abdul-Hai, Itamar Grotto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patientsIgor B Resnick, Panagiotis D Tsirigotis, Michael Y Shapira, et al.
Immunotherapy|July 20, 2010
Post-hematopoietic stem cell transplantion immune-mediated cytopeniasPanagiotis D Tsirigotis, Igor B Resnick, Reuven Or, et al.
British Journal of Haematology|May 18, 2006
Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimenIgor B Resnick, Memet Aker, Michael Y Shapira, et al.
Pageof 1